Eagle Pharmaceuticals Inc buy melinda
Start price
03.09.18
/
50%
€61.86
Target price
22.04.19
€71.71
Performance (%)
-30.46%
End price
22.04.19
€43.02
Summary
This prediction ended on 22.04.19 with a price of €43.02. Massive losses of -30.46% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Eagle Pharmaceuticals Inc | -13.061% | -13.061% | -83.228% | -87.898% |
| iShares Core DAX® | 2.594% | -1.861% | 13.242% | 16.867% |
| iShares Nasdaq 100 | 3.553% | -2.064% | 38.293% | 45.898% |
| iShares Nikkei 225® | 0.687% | -8.704% | 17.510% | 2.760% |
| iShares S&P 500 | 2.209% | -1.988% | 27.632% | 42.955% |
Comments by melinda for this prediction
In the thread Eagle Pharmaceuticals Inc diskutieren
SecteurProduits pharmaceutiques Agenda 13/09 | 22:05 Présentation
Develops and manufactures pharmaceutical preparations
Eagle Pharmaceuticals, Inc. engages in the provision of injectable products.
Its products include argatroban; ryanodex; docetaxel injection, non-alcohol formulation; and bendeka.
The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ.
Eagle Pharmaceuticals, Inc. engages in the provision of injectable products.
Its products include argatroban; ryanodex; docetaxel injection, non-alcohol formulation; and bendeka.
The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ.
Nombre d'employés : 108 personnes.
(Vom Mitglied beendet)
Stopped prediction by melinda for Eagle Pharmaceuticals Inc
Eagle Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€38.80
29.02.20
29.02.20
€55.00
04.11.21
04.11.21
14.43%
05.11.21
05.11.21
Eagle Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€48.30
27.07.17
27.07.17
€58.63
29.11.17
29.11.17
7.02%
29.11.17
29.11.17